Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3715_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
31 Мб
Скачать
References
https://t.me/medicina_free
59. Holman E, Willet F.Results of radical pericardiectomy for constrictive pericarditis. J Am Med Assoc. 1955;157:789–94.
60. Hayashi T, Tsuda E, Kurosaki K, etal. Electrocardiographic and clinical characteristics of idiopathic restrictive cardiomyopathy in children. Circ J. 2007;71(10):1534–9.
61. Hoit B, Sahn DJ, Shabetai R.Doppler-detected paradoxus of mitral and tricuspid valve ows in chronic lung disease. J Am Coll Cardiol. 1986;8:706.
62. Hadengue A, Poliquin M, Vilgrain V, etal. The changing scene of hepatic vein thrombosis: recognition of asymptomatic cases. Gastroenterology. 1994;106:1042–7.
63. Harter LP, Gross BH, Hilaire JS, Rilly RA, Goldberg HI.CT and sonographic appearance of hepatic vein obstruction. AJR. 1982;139:176–8.
64. Hakim JG, Manyemba J.Cardiac disease distribution among patients referred for echocar­diography in Harare. Zimbabwe Cent Afr J Med. 1998;44:140–4.
65. Hakim JG, Temouth I, Mushangi E, Siziya S, Robertson V, Malin A.Double blind randomised placebo controlled trial of adjunctive prednisolone in the treatment of effusive tuberculous pericarditis in HIV seropositive patients. Heart. 2000;84:183–8.
66. Hurrell DG, Nishimura RA, Higano ST, Appleton CP, Danielson GK, Holmes DR Jr, Tajik AJ.Value of dynamic respiratory changes in left and right ventricular pressures for the diag­nosis of constrictive pericarditis. Circulation. 1996;93:2007–13.
67. Ha JW, Ommen SR, Tajik AJ, Barnes ME, Ammash NM, Gertz MA, Seward JB, Oh JK.Differentiation of constrictive pericarditis from restrictive cardiomyopathy using mitral annular velocity by tissue Doppler echocardiography. Am J Cardiol. 2004;94:316–9.
68. Ha CB, Huh JY, Shin YW, Shin YK.Doppler ow patterns of constrictive pericarditis. Korean Circ J. 1989;19:47–54.
69. Hancock EW. On elastic and rigid forms of constrictive pericarditis. Am Heart J. 1980;100:917–23.
70. Ha JW, Ko YG, Choi BW.Images in cardiology. Delayed hyperenhancement of the pericar­dium by magnetic resonance imaging as a marker of pericardial inammation in a patient with tuberculous effusive constrictive pericarditis. Heart. 2006;92:494.
71. Hansen AT, Eskildsen P, Göotzsche H.Pressure curves from the right auricle and the right ventricle in chronic constrictive pericarditis. Circulation. 1961;3:881–8.
72. Hugo-Hamman CT, Scher H, De Moor MM.Tuberculous pericarditis in children: a review of 44 cases. Pediatr Infect Dis J. 1994;13:13–8.
73. Hageman JH, d’Esopo ND, Glenn WWL.Tuberculosis of the pericardium: a long-term anal­ysis of forty-four proved cases. N Engl J Med. 1964;270:327–32.
74. Harvey RM, Ferrer MI, Cathcart RT, Richards DW, Cournand A.Mechanical and myocardial factors in chronic constrictive pericarditis. Circulation. 1953;8:695–707.
75. Hancock EW. A clearer view of effusive-constrictive pericarditis. N Engl J Med. 2004;350:435–7.
76. Hancock EW.Neoplastic pericardial disease. Cardiol Clin. 1990;8:673–82.
77. Hancock EW.Subacute effusive constrictive pericarditis. Circulation. 1971;43:183–92.
78. Harrison MD, White PD.Chronic constrictive pericarditis: a follow-up study of 37 cases. Ann Int Med. 1942;17:790.
79. Hastillo A, Thompson JA, Lower RR.Cyclosporine induced pericardial effusion after cardiac transplantation. Am J Cardiol. 1987;59:1220–2.
80. Hellerstein HK, Santiago-Stevenson D.Atrophy of the heart: a correlative study of eighty­ve proved cases. Circulation. 1950;1:93.
81. Hinkamp TJ, Sullivan HJ, Montoya A, Park S, Bartlett L, Pifarre R.Chronic cardiac rejection masking as constrictive pericarditis. Ann Thorac Surg. 1994;57:1579–83.
82. Imazio M, Brucato A, Derosa FG, Lestuzzi C, Bombana E, Scipione F, Leuzzi S, Cecchi E, Trinchero R, Adler Y.Aetiological diagnosis in acute and recurrent pericarditis: when and how. J Cardiovasc Med. 2009;10:217–30.
83. Imazio M, Brucato A, Trinchero R, Adler Y.Diagnosis and management of pericardial dis­eases. Nat Rev Cardiol. 2009;6:743–51.
209
210
https://t.me/medicina_free
84. Imazio M, Spodick DH, Brucato A, Trinchero R, Adler Y.Controversial issues in the manage­ment of pericardial diseases. Circulation. 2010;121:916–28.
85. Imazio M, Spodick DH, Brucato A, Trinchero R, Markel G, Adler Y.Diagnostic issues in the clinical management of pericarditis. Int J Clin Pract. 2010;64:1384–92.
86. Imazio M, Trinchero R. Myopericarditis: aetiology, management, and prognosis. Int J Cardiol. 2008;127:17–26.
87. Imazio M, Trinchero R. Triage and management of acute pericarditis. Int J Cardiol. 2007;118:286–94.
88. Kothari SS, Roy A, Bahl VK.Chronic constrictive pericarditis: pending issues. Ind Heart J. 2003;55(4):1–8.
89. Klein AL, Oh JK, Miller FA, Seward JB, Tajik AJ.Two-dimensional and Doppler echocar­diographic assessment of inltrative cardiomyopathy. J Am Soc Echocardiogr. 1988;1:48.
90. Kumar R, Entrikin DW, Ntim WO, Carr JJ, Kincaid EH, Hines MH, Oaks TE, Thohan V, etal. Constrictive pericarditis after cardiac transplantation: a case report and literature review. J Heart Lung Transplant. 2008;27(10):1158–61.
91. Kiley S, Soa J, Machuca T.Venoarterial ECMO for recovery from right ventricular failure after pericardiectomy. SOCCA Post Session 2017 (Abstract), No. 1344.
92. Ling LH, Oh JK, Schaff HV, Danielson GK, Mahoney OW, Seward JB, Tajik JA.Constrictive pericarditis in the modern era: evolving clinical spectrum and impact on outcome after peri­cardiectomy. Circulation. 1999;100:1380–6.
93. Ling LH, Oh JK, Breen JF, Schaff JV, Danielson GK, Mahoney DW, Seward JB, Tajik AJ.Calcic constrictive pericarditis: is it still with us? Ann Intern Med. 2000;132:444–50.
94. Langlet P, Escolano S, Valla D, et al. Clinicopathological forms and prognostic index in Budd-Chiari syndrome. J Hepatol. 2003;39:496–501.
95. Larrieu AJ, Tyers GF, Williams EH, Derrick JR.Recent experience with tuberculous pericar­ditis. Ann Thorac Surg. 1980;29:464–8.
96. Lee JH, Lee CW, Lee SG, Yang HS, Hong MK, Kim JJ, Park SW, Chi HS, Park SJ.Comparison of polymerase chain reaction with adenosine deaminase activity in pericardial uid for the diagnosis of tuberculous pericarditis. Am J Med. 2002;113:519–21.
97. Latouf SE, Ress SR, Lukey PT, Commerford PJ.Interferongamma in pericardial aspirates: a new, sensitive and specic test for the diagnosis of tuberculous pericarditis. Circulation. 1991;84:II-149.
98. Latouf SE, Levetan BN, Commerford PJ.Tuberculous pericardial effusion: analysis of com­monly used diagnostic methods. S Afr Med J. 1996;86(suppl):15.
99. Levine HD, Ford RV.Subendocardial infarction: report of six cases and critical survey of the literature. Circulation. 1950;1:246.
100. Loire R, Tabib A, Roux N, Dureau G, etal. Pericardium and heart transplantation. Arch Mal Coeur Vaiss. 1994;84:467–73.
101. Levine HD.Myocardial brosis in constrictive pericarditis: electrocardiographic and patho­logic observations. Circulation. 1973;48:1268–81.
102. McDermott WV, Stone MD, Bothe A, Trey C.Budd-Chiari syndrome: historical and clinical review with analysis of surgical corrective procedures. Am J Surg. 1984;147:463–7.
103. Myers RB, Spodick DH.Constrictive pericarditis: clinical and pathophysiologic chararcter­istics. Am Heart J. 1999;138:219–32.
104. Maisch B, Bethge C, Drude L, Hufnagel G, Herzum M, SchÜnian U.Pericardioscopy and epicardial biopsy- new diagnostic tools in pericardial and perimyocardial disease. Eur Heart J. 1994;15:68–73.
105. Maisch B, Seferović PM, Ristić AD, Erbel R, Rienmüller R, Adler Y, Tomkowski WZ, Thiene G, Yacoub MH, Priori SG, Alonso Garcia MA.Guidelines on the diagnosis and management of pericardial diseases executive summary: the task force on the diagnosis and management of pericardial diseases of the European Society of Cardiology. Eur Heart J. 2004;25(7):587–610.
106. Muchtar E, Blauwet LA, Gertz MA. Restrictive cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy. Circ Res. 2017;121(7):819–37.
11 Management ofChronic Constrictive Pericarditis
References
https://t.me/medicina_free
107. Mor-Avi V, Lang RM, Badano LP, Belohlavek M, Cardim NM, Derumeaux G, Galderisi M, Marwick T, Nagueh SF, Sengupta PP, Sicari R.Current and evolving echocardiographic tech­niques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography. Eur J Echocard. 2011;12(3):167–205.
108. MacGregor JH, Chen JT, Chiles C, Kier R, Godwin JD, Ravin CE.The radiographic distinc­tion between pericardial and myocardial calcications. Am J Roentgenol. 1987;148(4):675–7.
109. McCaughan BC, Schaff HV, Piehler JM, Danielson GK, Orszulak TA, Puga FJ, Pluth JR, Connolly DC, McGoon DC.Early and late results of pericardiectomy for constrictive peri­carditis. J Thorac Cardiovasc Surg. 1985;89(3):340–50.
110. Mayosi BM, Burgess LJ, Doubell AF. Tuberculous pericarditis. Circulation. 2005;112(23):3608–16.
111. Mayosi BM, Wiysonge CS, Ntsekhe M, etal. Clinical characteristics and initial management of patients with tuberculous pericarditis in the HIV era: the investigation of the management of pericarditis in Africa (IMPI Africa) registry. BMC Infect Dis. 2006;6:2.
112. Mayosi BM, Wiysonge CS, Ntsekhe M, Gumedze F, Volmink JA, Maartens G, Aje A, Thomas BM, Thomas KM, Awotedu AA, Thembela B.Mortality in patients treated for tuberculous pericarditis in sub-Saharan Africa. South Afr Med J. 2008;98(1):36–40.
113. Mayosi BM.Contemporary trends in the epidemiology and management of cardiomyopathy and pericarditis in sub-Saharan Africa. Heart. 2007;93(10):1176–83.
114. Maher D, Harries AD.Tuberculous pericardial effusion: a prospective clinical study in a low­resource setting-Blantyre. Malawi Int J Tubercul Lung Dis. 1997;1(4):358–64.
115. Mayosi BM, Ntsekhe M, Volmink JA, Commerford PJ. Interventions for treating tuber­culous pericarditis. Cochrane Database Syst Rev. 2002;4:CD000526. https://doi.
org/10.1002/14651858.CD000526.
116. Maisch B, Maisch S, Kochsiek K.Immune reactions in tuberculous and chronic constric­tive pericarditis: clinical data and diagnostic signicance of antimyocardial antibodies. Am J Cardiol. 1982;50(5):1007–13.
117. Miller JI, Mansour KA, Hatcher CR Jr. Pericardiectomy: current indications, concepts, and results in a university center. Ann Thorac Surg. 1982;34(1):40–5.
118. Mercé J, Sagristà-Sauleda J, Permanyer-Miralda G, Soler-Soler J.Should pericardial drain­age be performed routinely in patients who have a large pericardial effusion without tampon­ade? Am J Med. 1998;105(2):106–9.
119. Moores DW, Allen KB, Faber LP, Dziuban SW, Gillman DJ, Warren WH, Ilves R, Lininger L. Subxiphoid pericardial drainage for pericardial tamponade. J Thorac Cardiovasc Surg. 1995;109(3):546–52.
120. Nagueh SF, Lakkis NM, Middleton KJ, Spencer WH III, Zoghbi WA, Quinones MA.Doppler estimation of left ventricular lling pressures in patients with hypertrophic cardiomyopathy. Circulation. 1999;99(2):254–61.
121. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quiñones MA.Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of lling pressures. J Am Coll Cardiol. 1997;30(6):1527–33.
122. Nagueh SF, Smiseth OA, Appleton CP, etal. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016;29(4):277–314.
123. Ntsekhe M, Wiysonge CS, Gumedze F, Maartens G, Commerford PJ, Volmink JA, Mayosi BM.HIV infection is associated with a lower incidence of constriction in presumed tubercu­lous pericarditis: a prospective observational study. PLoS One. 2008;3(6):e2253.
124. Ng TT, Strang JI, Wilkins EG.Humoral response to mycobacterial heat shock proteins in patients with constrictive pericarditis caused by tuberculosis and its implications for patho­genesis. Clin Diagn Lab Immunol. 1994;1(5):552–5.
211
212
https://t.me/medicina_free
125. Ntsekhe M, Wiysonge C, Volmink JA, Commerford PJ, Mayosi BM.Adjuvant corticoste­roids for tuberculous pericarditis: promising, but not proven. QJM. 2003;96(8):593–9.
126. Ntsekhe M, Hakim J.Impact of human immunodeciency virus infection on cardiovascular disease in Africa. Circulation. 2005;112(23):3602–7.
127. Narita M, Ashkin D, Hollender ES, Pitchenik AE. Paradoxical worsening of tuberculo­sis following antiretroviral therapy in patients with AIDS. Am J Resp Crit Care Med. 1998;158:157–61.
128. Plessier A, Valla DC.Budd-Chiari syndrome. Semin Liver Dis. 2008;28(3):259–69.
129. Pozniak AL, Weinberg J, Mahari M, Neill P, Houston S, Latif A.Tuberculous pericardial effusion associated with HIV infection: a sign of disseminated disease. Tuber Lung Dis. 1994;75(4):297–300.
130. Palatianos GM, Thurer RJ, Pompeo MQ, Kaiser GA.Clinical experience with subxiphoid drainage of pericardial effusions. Ann Thorac Surg. 1989;48(3):381–5.
131. Pinkney KA, Minich LL, Tani LY, Di Russo GB, Veasy LG, McGough EC, Hawkins JA.Current results with intraaortic balloon pumping in infants and children. Ann Thorac Surg. 2002;73(3):887–91.
132. Reuss CS, Wilansky SM, Lester SJ, Lusk JL, Grill DE, Oh JK, etal. Using mitral 'annulus reversus' to diagnose constrictive pericarditis. Eur J Echocardiogr. 2009;10:372–5.
133. Reisinger J, Dubrey SW, Lavalley M, etal. Electrophysiologic abnormalities in AL (primary) amyloidosis with cardiac involvement. JAm Coll Cardiol. 1997;30(4):1046–51.
134. Reuter H, Burgess L, van Vuuren W, Doubell A.Diagnosing tuberculous pericarditis. Q J Med. 2006;99:827–39.
135. Reuter H, Burgess LJ, Doubell AF.Epidemiology of pericardial effusions at a large academic hospital in South Africa. Epidemiol Infect. 2005;133:393–9.
136. Reuter H, Burgess LJ, Louw VJ, Doubell AF.The management of tuberculous pericardial effusion: experience in 233 consecutive patients. Cardiovasc J S Afr. 2007;18:20–5.
137. Reuter H, Burgess LJ, Schneider J, Van Vururen W, Doubell AF.The role of histopathol­ogy in establishing the diagnosis of tuberculous pericardial effusions in the presence of HIV.Histopathology. 2006;48:295–302.
138. Reuter H, Burgess LJ, Louw VJ, Doubell AF.Experience with adjunctive corticosteroids in managing tuberculous pericarditis. Cardiovasc J S Afr. 2006;17:233–8.
139. Rooney JJ, Crocco JA, Lyons HA.Tuberculous pericarditis. Ann Intern Med. 1970;72:73–81.
140. Rodriguez E, Soler R, Juffe A, Salgado L.CT and MR ndings in a calcied myocardial tuberculoma of the left ventricle. J Comput Assist Tomogr. 2001;25:577–9.
141. Shaper AG. Cardiovascular disease in the tropics. II Endomyocardial brosis. BMJ. 1972;3:743–6.
142. Shabetai R. Pathophysiology and differential diagnosis of restrictive cardiomyopathy. Cardiovasc Clin. 1988;19:123–32.
143. Shaper AG.The aetiology of endomyocardial brosis. In: Valiathan MS, Somers K, Kartha CC, editors. Endomyocardial brosis. New Delhi: Oxford University Press; 1993. p.111–20.
144. Schoenfeld MH, Edwards WS, William GD Jr, etal. Restrictive cardiomyopathy versus con­strictive pericarditis-role of endomyocardial biopsy in avoiding unnecessary thoracotomy. Circulation. 1987;75:1012–7.
145. Shrestha SM, Okuda K, Uchida T, etal. Endemicity and clinical picture of liver disease due to obstruction of the hepatic portion of the inferior vena cava in Nepal. J Gastroenterol Hepatol. 1996;11:170–9.
146. Sengupta P, Eleid MF, Sundt TM.Regional variability of pericardial thickness inuences left ventricular diastolic recoil mechanics in constrictive pericarditis. J Am Soc Echocardiogr. 2008;21:518.
147. Sengupta PP, Eleid MF, Khandheria BK.Constrictive pericarditis. Circ J. 2008;72:1555–62.
148. Sengupta PP, Krishnamoorthy VK, Abhayaratna WP, etal. Disparate patterns oeft ventricu­lar mechanics differentiate constrictive pericarditis from restrictive cardiomyopathy. JACC Cardiovasc Imaging. 2008;1(1):29–38.
11 Management ofChronic Constrictive Pericarditis
References
https://t.me/medicina_free
149. Sengupta PP, Mohan JC, Mehta V, Arora R, Pandian NG, Khandheria BK.Accuracy and pitfalls of early diastolic motion of the mitral annulus for diagnosing constrictive pericarditis by tissue Doppler imaging. Am J Cardiol. 2004;93:886–90.
150. Sankhyan LK, Yadav V, Sharma S, Choubey M, George N, Sushamagayatri B, Malik V, Chowdhury UK.Assessment of myocardial mechanics in patients undergoing pericardiec­tomy for chronic constrictive pericarditis by tissue doppler imaging and 2D speckled track­ing echocardiography: a prospective observational (Cohort) study. J Clin Cardiol Cardiovasc Interven. 4(3). https://doi.org/10.31579/2641- 0419/115.
151. Shabetai R, Fowler NO, Guntheroth WG.The haemodynamics of cardiac tamponade and constrictive pericarditis. Am J Cardiol. 1970;26:480–9.
152. Shabetai R. Left ventricular function and myocardial contractility in chronic constrictive pericarditis. Chest. 1971;59:476–7.
153. Schwefer M, Aschenbach R, Heidemann J, Mey C, Lapp H.Constrictive pericarditis, still a diagnostic challenge: Comprehensivereview of clinical management. Eur J CardiothoracSurg. 2009;36:502–10.
154. Seth S, Thatai D, Sharma S, etal. Clinico-pathological evaluation of restrictive cardiomyopa­thy (endomyocardial brosis and idiopathic restrictive cardiomyopathy) in India. Eur J Heart Fail. 2004;6(6):723–9.
155. Sasidharan K, Balakrishnan KG, Venkitachalam CG, Sapru RP. Radiological features of endomyocardial brosis. Indian Heart J. 1980;32:234.
156. Sipe JD, Cohen AS.Review: history of the amyloid bril. J Struct Biol. 2000;130(2–3):88–98.
157. Sachchithanantham S, Wechalekar AD. Imaging in systemic amyloidosis. Br Med Bull. 2013;107:41–56.
158. Scholtz W, etal. Severe calcication of the latral mitral annulus in constrictive pericarditis: a potential pitfall for the use of echocardiographic tissue Doppler imaging. Eur J Echocardiogr. 2008;9:403–5.
159. Schepers GWH.Tuberculous pericarditis. Am J Cardiol. 1962;9:248–76.
160. Spodick DH.Tuberculous pericarditis. Arch Intern Med. 1956;98:737–49.
161. Sagrista-Sauleda J, Angel J, Permanyer-Miralda G, Soler-Soler J. Long-term follow-up of idiopathic chronic pericardial effusion. N Engl J Med. 1999;341:2054–9.
162. Strang JI.Rapid resolution of tuberculous pericardial effusions with high dose prednisone and antituberculous drugs. J Infect. 1994;28:251–4.
163. Strang JI, Nunn AJ, Johnson DA, Casbard A, Gibson DG, Girling DJ.Management of tuber­culous constrictive pericarditis and tuberculous pericardial effusion in Transkei: results at 10 years follow-up. QJM. 2004;97:525–35.
164. Strang JI.Tuberculous pericarditis in Transkei. Clin Cardiol. 1984;7:667–70.
165. Strang JIG, Kakaza HHS, Gibson DG, Allen BW, Mitchison DA, Evans DJ, etal. Controlled clinical trial of complete open surgical drainage and of prednisolone in treatment of tubercu­lous pericardial effusion in Transkei. Lancet. 1988;2:759–64.
166. Spodick DH.Infective pericarditis. Etiologic and clinical spectra. In: Reddy PS, Leon DF, Shaver JA, editors. Pericardial disease. NewYork: Raven Press; 1982. p.307–32.
167. Spodick DH.Diagnostic electrocardiographic sequences in acute pericarditis: signicance of PR segment and PR vector changes. Circulation. 1973;48:575–80.
168. Strang JI.Tuberculous pericarditis. In: Campbell GD, Seedat YK, Daynes G, editors. Clinical medicine and health in developing Africa. Cape Town: David Philip; 1982. p.145–9.
169. Syed FF, Mayosi BM.A modern approach to tuberculous pericarditis. Prog Cardiovasc Dis. 2007;50(3):218–36.
170. Sagrista-Sauleda J, Merce J, Permanyer-Miralda G, Soler-Soler J.Clinical clues to the causes of large pericardial effusions. Am J Med. 2000;109:95–101.
171. Sagrista-Sauleda J, Permanyer-Miralda G, Soler-Soler J.Tuberculous pericarditis: ten year experience with a prospective protocol for diagnosis and treatment. J Am Coll Cardiol. 1988;11:724–8.
213
214
https://t.me/medicina_free
172. Salem MH, Wilson JR.Tuberculous pericarditis. Evaluation of forty-seven cases at Duke Hospital. J Int Coll Surg. 1960;33:535–41.
173. Sahn SA, Neff TA.Miliary tuberculosis. Am J Med. 1974;56:495–505.
174. Strang G, Latouf S, Commerford P, Roditi D, Duncan-TraiIl G, Barlow D, etal. Bedside culture to conrm tuberculous pericarditis. Lancet. 1991;338:1600–1.
175. Strang JI, Kakaza HH, Gibson DG, Girling DJ, Nunn AJ, Fox W.Controlled trial of pred­nisolone as adjuvant in treatment of tuberculous constrictive pericarditis in Transkei. Lancet. 1987;2:1418–22.
176. Sagrista-Sauleda J, Almenar Bonet L, Angel Ferrer J, Bardají Ruiz A, Bosch Genover X, Guindo Soldevila J, et al. The clinical practice guidelines of the Sociedad Espanola de Cardiologia on pericardial pathology. Rev Esp Cardiol. 2000;53:394–412.
177. Senderovitz T, Viskum K.Corticosteroids and tuberculosis. Respir Med. 1994;88:561–5.
178. Syed FF, Schaff HV, Oh JK.Constrictive pericarditis-a curable diastolic heart failure. Nat Rev Cardiol. 2014;11:530–44.
179. Spodick DH.Constrictive pericarditis. In: Spodick DH, editor. The pericardium: a compre­hensive textbook. 1st ed. NewYork: Marcel Dekker, Inc; 1997. p.214–59.
180. Spodick DH.Pericardial macro-and microanatomy: a synopsis. In: Spodick DH, editor. The pericardium: a comprehensive textbook. NewYork, NY: Marcel Dekker; 1997. p.7–14.
181. Spodick DH. The pericardium. A comprehensive textbook, vol. 233. New York, NY: M.Dekker; 1997. p.464.
182. Spodick DH.Pericardial diseases. In: Braunwald E, Zipes DP, Libby P, editors. Heart disease: a textbook of cardiovascular medicine, vol. 6. Philadelphia, PA: WB Saunders Co; 2001. p.1823–70.
183. Sagrista-Sauleda J.Pericardial constriction: uncommon patterns. Heart. 2004;90:257–8.
184. Sagrista-Sauleda J, Angel J, Sánchez A, Permanyer-Miralda G, Soler-Soler J. Effusive­constrictive pericarditis. N Engl J Med. 2004;350:469–75.
185. Salami MA, Adeoye PO, Adegboye VO, Adebo OA.Presentation pattern and management of effusive-constrictive pericarditis in Ibadan. Cardiovasc J Afr. 2012;23:206–11.
186. Syed FF, Menasche M, Mayosi BM, Oh JK.Effusive-constrictive pericarditis. Heart Fail Rev. 2013;18:277.
187. Seferovic PM, Ristic AD, Imazio M, Maksimovic R, Simeunovic D, Trinchero R, et al. Management strategies in pericardial emergencies. Herz. 2006;31:891–900.
188. Szabo G, Schmack B, Bulut C, Soos P, Weymann A, Stadtfeld S, etal. Constrictive pericardi­tis: risks, aetiologies and outcomes after total pericardiectomy: 24 years of experience. Eur J of Cardiothorac Surg. 2013;44:1023–8.
189. Tharakan J, Bohora S. Current perspective on endomyocardial brosis. Curr Sci. 2009;97:405–10.
190. Tharakan JA.Electrocardiography in endomyocardial brosis. Indian Pacing Electrophysiol J. 2011;11:129–33.
191. Talreja DR, Edwards WD, Danielson GK, Schaff HV, Tajik AJ, Tazelaar HD, Breen JF, Oh JK.Constrictive pericarditis in 26 patients with histologically normal pericardial thickness. Circulation. 2003;108:1852–7.
192. Tharakan JM, Venkatachalam CG, Balakrishnan KG.Angiographic features of endomyo­cardial brosis. In: Valiathan MS, editor. Endomyocardial brosis. New Delhi: Oxford University Press; 1993. p.168–84.
193. Talwar KK, Kumar V, Chopra P, etal. Endomyocardial biopsy study in patients with restric­tive cardiomyopathy. In: Valiathan MS, Somers K, Kartha CC, editors. Endomyocardial brosis. New Delhi: Oxford University Press; 1993. p.185–94.
194. Talwar KK, Narula JP, Chopra P.Myocarditis and myocardial interstitial brosis in constric­tive pericarditis-an extended pathological spectrum. Int J Cardio. 1990;29(2):241–3.
195. Tang TJ, Batts KP, de Groen PC, etal. The prognostic value of histology in the assessment of patients with Budd-Chiari syndrome. J Hepatol. 2001;35:338–43.
11 Management ofChronic Constrictive Pericarditis
References
https://t.me/medicina_free
196. Tezuka D, Terashima M, Kato Y, Toriihara A, Hirasawa K, Sasaoka T, Yoshikawa S, Maejima Y, Ashikaga T, Suzuki J, Hirao K, Isobe M.Clinical characteristics of denite or suspected isolated cardiac sarcoidosis: application of cardiac magnetic resonance imaging and 18F-Fluoro-2-deoxyglucose positron-emission tomography/computerized tomography. J Card Fail. 2015;21:313–22.
197. Torres WE, Whitmire LF, Gedgaudas-McClees K, Bernardino ME.CT of hepatic morpho­logic changes in cirrhosis of the liver. J Comput Assist Tomogr. 1986;10:47–50.
198. Tchana-Sato V, Ancion A, Ansart F, Defraigne JO.Constrictive pericarditis after heart trans­plantation: a case report. Eur Heart J. 2020;4:1–6.
199. Tokuda Y, Miyata H, Motomura N, Araki Y, Oshima H, et al. Outcome of pericardiec­tomy for constrictive pericarditis in Japan: a nationwide outcome study. Ann Thorac Surg. 2013;96:571–6.
200. Umer A, Khalid N, Chhabra L, Memon S, Spodick DH.Constrictive pericarditis complicat­ing cardiac transplantation. J Cardiothorac Surg. 2015;10:109.
201. Valiathan MS, Balakrishnan KG, Kartha CC.Endomyocardial brosis. In: Ahuja MMS, edi­tor. Advances in clinical medicine. New Delhi: Churchill Livingstone; 1991. p.125–43.
202. Voelkel AG, Pietro DA, Folland ED, Fisher ML, Parisi AF.Echocardiographic features of constrictive pericarditis. Circulation. 1978;58:871–5.
203. Valla DC.Hepatic vein thrombosis (Budd-Chiari syndrome). Semin Liver Dis. 2002;22:5–14.
204. Veress G, Ling LH, Kim KH, Dal-Bianco JP, Schaff HV, Espinosa RE, Melduni RM, Tajik JA, Sundt TM 3rd, Oh JK.Mitral and tricuspid annular velocities before and after pericardi­ectomy in patients with constrictive pericarditis. Circ Cardiovasc Imaging. 2011;4:399–407.
205. Verhaert D, Gabriel RS, Johnston D, Lytle BW, Desai MY, Klein AL.The role of multi­modality imaging in the management of pericardial disease. Circ Cardiovasc Imaging. 2010;3:333–43.
206. Von Bibra H, Schober K, Jenni R, Busch R, Sebening H, Blomer H.Diagnosis of constric­tive pericarditis by pulsed Doppler echocardiography of the hepatic vein. Am J Cardiol. 1989;63:483–8.
207. Venkatachalam CG, Balakrishanan KG, Tharakan JM.Echocardiographic ndings in endo­myocardial brosis. In: Valiathan MS, editor. Endomyocardial Fibrosis. New Delhi: Oxford University Press; 1993. p.153–67.
208. Vita T, Dr O, Veillet-Chowdhury M, etal. Complementary value of cardiac magnetic reso­nance imaging and positron emission tomography/computed tomography in the assessment of cardiac sarcoidosis. Circ Cardiovasc Imaging. 2018;11(1):e007030.
209. Westermark P, Benson MD, Buxbaum IN, etal. A primer of amyloid nomenclature. Amyloid Int J Exp Clin Invest. 2007;14(3):179–83.
210. Wiysonge CS, Ntsekhe M, Gumedze F, et al. Contemporary use of adjunctive corticoste­roids in tuberculous pericarditis. Int J Cardiol 2007 (in press). https://doi.org/10.1016/j.
ijcard.2006.12.060.
211. Wiysonge CS, Ntsekhe M, Gumedze F, etal. Excess mortality in presumed tuberculous peri­carditis. Eur Heart J. 2006;27:958.
212. Wiysonge CS, Ntsekhe M, Mayosi BM.Initial report of the initiative investigate the optimal Management of Tuberculous? Africa J Am Call Cardiol. 2005;45:141A.
213. Wood JA.Tuberculous pericarditis; a study of fortyone cases with special reference to prog­nosis. Am Heart J. 1951;42:737–45.
214. World Health Organization. Treatment of Tuberculosis. Guidelines. WHO/HTM/TB/2009. 420 4th ed. Geneva: World Health Organization; 2010.
215. Zurick AO, Bolen MA, Kwon DH, Tan CD, Popovic ZB, Rajeswaran J, et al. Pericardial delayed hyperenhancement with CMR imaging in patients with constrictive pericarditis undergoing surgical pericardiectomy: a case series with histopathological correlation. JACC Cardiovasc Imaging. 2011;4:1180–91.
216. Zhu P, Mai M, Wu R, Lu C, Fan R, Zheng S.Pericardiectomy for constrictive pericarditis: single-Centre experience in China. J Cardiothorac Surg. 2015;10:34.
215
Chapter 12
https://t.me/medicina_free
Decision-Making ontheTimings ofPericardiectomy, Selection oftheOptimal Surgical Approach, Adequacy ofPericardiectomy andRequirement ofCardiopulmonary Bypass
Despite experience spanning more than 300years, there is no fool-proof formula in the published literature to decide on the timing of pericardiectomy, optimal surgical approach, extent of decortication, and requirement of cardiopulmonary bypass for a given patient. The literature is rife with descriptions of pericardiectomy by either left anterolateral thoracotomy or median sternotomy. Despite the effectiveness of surgery, there are disparate opinions regarding the role of corticosteroids in treating tuberculous pericarditis, timing of operation, surgical approach, extent of decortica­tion, and requirement of cardiopulmonary bypass [129, 34, 3840, 50, 51, 57, 59,
62, 6668, 74100]. The efcacy of pericardiocentesis in preventing chronic con-
strictive pericarditis in pericardial effusion (serous or hemorrhagic) has been inad­equately investigated [57, 58, 7476]. The terms “total”, “complete”, “extensive”, “radical”, “partial”, “subtotal” and “near-total” pericardiectomy have been variably used to describe the procedure, often without precise denition of the limits of peri­cardial resection [4, 1123, 3840, 50, 5759, 69].
Published reports attest to the unpredictable and variable pattern of clinical pre­sentation of chronic constrictive pericarditis, and lend support to radical decortica­tion [5, 1127, 7477, 100]. In 2005, to dene the limit of pericardial resection, total pericardiectomy was dened as wide excision of the pericardium with the phrenic nerves dening the posterior extent, the great vessels including the intra­pericardial portion of superior caval vein and superior cavoatrial junction dening the superior extent, and the diaphragmatic surface, including the inferior cavoatrial junction dening the inferior extent of the pericardial resection [19]. Constricting layers of the epicardium were removed whenever possible and the atria and caval veins were decorticated in all cases in this study group. Pericardiectomy was con­sidered partial if both ventricles could not be decorticated completely because of dense myopericardial adhesions or calcication [27]. Radical pericardiectomy was dened as removal of the entire pericardium over the anterolateral, diaphragmatic surfaces of the left ventricle, portion of pericardium posterior to the phrenic nerves and the left ventricle, and the anterior and diaphragmatic surfaces of right ventricle
Ltd. 2023 U. K. Chowdhury, L. K. Sankhyan, Surgical Treatment of Chronic Constrictive Pericarditis, https://doi.org/10.1007/978-981-99-5808-5_12
217© The Author(s), under exclusive license to Springer Nature Singapore Pte
218
https://t.me/medicina_free
until the atrioventricular groove, leaving behind intact left and right phrenic pedi­cles [19].
“total pericardiectomy” when a patient had a wide pericardial excision over the anterolateral, diaphragmatic surfaces of both ventricles, the pericardium posterior to the phrenic nerves with intact phrenic pedicles, and over the great vessels including the intrapericardial cavoatrial junctions [27]. The term “partial pericardiectomy” is reserved for anything less than total pericardiectomy [19]. “Radical pericardiec­tomy” will be more dened in terms of relation to oncological situations where draining lymphatics/lymph nodes will be removed as well. In addition, “radical pericardiectomy” is something that is never possible as it requires removal of all three layers of pericardium, which are “brous” and “serous” with two components: “parietal and visceral epicardium”, and that is not possible in real life [27].
described by Harrington in 1944; successful pericardiectomy requires removal of all constricting layers including decortication of the ventricular epicardium [38, 39]. In a study, Kloster and associates demonstrated normalization of the pressure vol­ume loop as an indicator of operative success of pericardiectomy [47].
12 Decision-Making on the Timings of Pericardiectomy, Selection of the Optimal…
Subsequently, in 2020 for the sake of uniformity with other studies, we redened
Secondly, the importance of unrecognized constricting epicardial peel was
12.1 Anatomical Basis oftheAdequacy ofPericardiectomy
In constrictive pericarditis, the diseased, brotic pericardial cavity causes impair­ment of myocardial function by limiting ventricular diastolic lling resulting in decreased cardiac output [40, 41]. It stands to reason, therefore, that the aim of surgery would be to physically release the encased ventricles, thereby facilitating improvement of cardiac output.
In an attempt to provide a functional anatomical perspective for performance and recovery of the heart during pericardiectomy, Lachman and colleagues in a nec­ropsy study demonstrated that although the anterior pericardium between the phrenic nerves constitutes about 58% of total selected pericardial area, the total pericardium accessible over the left ventricle was only 26%. When oriented in the left anterolateral position, the total area of the left ventricular pericardium was 37% [50]. From a physiological perspective, the recovery of the heart through increased cardiac output is dependent primarily on the release of the left ventricular cham­ber [50].
In 1946, Sellors TH and colleagues stated that the restraining pericardium should be removed to allow maximum ventricular expansion. The procedure should be aimed primarily and possibly only at removal of ventricular pericardium. Sellors goes on to state that the correct dissection should be carried out posteriorly beyond the phrenic nerves [78].
As the diastolic volume of the heart is directly related to sarcomere length, it is reasonable to explain Starling’s law in terms of the ultrastructure of the myocardial cell. As the sarcomere is progressively stretched to its optimal length, the diastolic
12.2 Criteria for Decision-Making on the Indications and Timings for Pericardiectomy…
https://t.me/medicina_free
bre lengthens proportionately, and the force of contraction progressively increases. If the sarcomere is overstretched, less force is generated and effective contractility is decreased [41, 78, 79, 101, 107]. In cases of incomplete pericardiectomy the patient goes into a state of severely low cardiac output. It is therefore critical to release the left ventricle for complete functional recovery and regression of symptoms.
219
12.2 Criteria forDecision-Making ontheIndications
andTimings forPericardiectomy, Selection oftheOptimal Surgical Approach, Adequacy ofSurgical Resection, andTheir Relationship toMortality andLow Cardiac Output Syndrome
In 2005, we compared two surgical approaches, for pericardiectomy, clinically, echocardiographically and haemodynamically in 395 patients undergoing pericardi­ectomy for chronic constrictive pericarditis at All India Institute of Medical Sciences, New Delhi, India. The approach for pericardiectomy was subjective and remained uniform during the period of study [19].
We concluded that maximum benet could be achieved following total pericar­diectomy which was best achieved through a median sternotomy and was indeed difcult to achieve through a conventional left anterolateral thoracotomy [24, 27].
Total pericardiectomy was associated with superior short- and long-term out­comes namely, lower perioperative and late mortalities, less postoperative low car­diac output syndrome, early normalization of hemodynamics, shorter hospitalization, and better long-term survival than partial pericardiectomy [27]. The risk of death was 4.5 times higher (95% CI 2.05, 9.75) in patients undergoing partial pericardiec­tomy as compared to total pericardiectomy.
At a mean follow-up of 17.9±0.3years, it was demonstrated that late presenta­tion was associated with advanced functional class, higher right-sided lling pres­sure, supraventricular dysrhythmias, hepatorenal dysfunction, and pericardial calcication.
Cox regression analysis identied the following predictors of mortality follow­ing pericardiectomy (Hazard ratio, 95% CI, p value): elevated right- sided lling pressure more than 20–24mmHg: 5.62 (1.25–22.84), p=0.002; hyperbilirubine­mia: 7.92 (1.98–64.02), p=0.042; renal dysfunction: 4.95 (1.05–23.42), p=0.044; atrial brillation: 4.70 (1.76–12.58),p = 0.002; pericardial calcication: 9.49 (3.94–22.90), p < 0.001; and extent of pericardiectomy (partial/total): 4.45 (2.05–9.75), p=0.002 [19, 27]. Reoperations for recurrent pericarditis after partial pericardiectomy via conventional left anterolateral thoracotomy are common [19,
77, 78].
cavoatrial junctions could be achieved via median sternotomy, these areas are of
,
Although a greater degree of pericardial resection over the right atrium and the